Skip to content

Use of cold preservative in inducing hypothermia of newborns with encephalopathy

The effect of using cold preservative serum on hypothermia in newborns with moderate to severe hypoxia ischemic encephalopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190204042609N1
Enrollment
50
Registered
2019-06-27
Start date
2018-11-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic hypoxic episma encephalopathy.

Interventions

Intervention 1: Intervention group: Infants with moderate to severe HIE. Intervention 2: Control group: Infants with moderate to severe HIE with conventional treatment.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Apgar score less than 5 in 10 minutes after the birth or need of the baby to continue the regenerative process (including ventilation with mask and intubation) until 10 minutes after birth or acidosis in the first hour after birth (PH in umbilical cord or arterial blood and Or capillary blood less than 7) or a base deficiency greater than 16 millimoles / liter in any of the blood samples within 60 minutes of the first birth Clinical manifestations of moderate to severe postpartum encephalopathy

Exclusion criteria

Exclusion criteria: Parental dissatisfaction at each stage of induction cooled therapy The infant's center temperature reaches more than 38 degrees Celsius Neonatal abnormalities require surgery Newborns with obvious anomalies require immediate intervention such as cyanatoid heart disease In case of possible complications of treatment, a newborn resuscitation, such as severe bradycardia associated with apnea

Design outcomes

Primary

MeasureTime frame
Infants with moderate to severe HIE. Timepoint: Duration 48 to 72 hours of birth. Method of measurement: Clinical-Biochemical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Adineh

Mashhad University of Medical Sciences

saba671388@gmail.com+98 51 3852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026